Category Archives: News

Eli Lilly’s Reyvow, squaring off against AbbVie and Biohaven, posts data showing early and lasting migraine relief

With several new acute migraine treatments vying for market share, Eli Lilly is touting new data on Reyvow showing the med can provide patients “pain freedom” in as little as one hour, plus sustained relief for up to two days. In a phase 3 trial called Centurion, patients who took Lilly’s new drug at the 200mg dose were 4.6 times more likely to experience pain… Read More: Eli Lilly’s Reyvow, squaring off against AbbVie and Biohaven, posts… »

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More: FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of… »

Patient Identity and Patient Record Matching

Health Policy Sep 11, 2020• By ADRIAN GROPPER and DEBORAH C. PEEL September 4, 2020 Thank you, ONC for the opportunity you gave me to speak in June. Also, thank you for the format of your August meeting where the Zoom chat feature offered a wonderful venue for an inclusive commentary and discussion as the… Read More: Patient Identity and Patient Record Matching »

The Latest: Domestic air travel recovers in Wuhan, China

BEIJING — Domestic air travel in Wuhan, the epicenter of the global coronavirus outbreak, has returned to pre-pandemic levels, authorities say. The virus was first detected in Wuhan late last year and the city underwent a draconian 76-day lockdown as its hospitals struggled to deal with a tidal wave of cases that required the rapid… Read More: The Latest: Domestic air travel recovers in Wuhan, China »